Short answer
Labcorp (LH) filed an 8-K current report with the SEC on October 28, 2026 reporting Item EX-99.1 (Exhibit EX-99.1). Q3 revenue $3.81B, up 6.9%, with adjusted EPS $4.78, up 14.5%, signaling continued operating leverage.
Labcorp 8-K event analysis
AI summary of each reported item and its exhibits
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $3.81B, up 6.9%, with adjusted EPS $4.78, up 14.5%, signaling continued operating leverage
- Adjusted operating margin expanded to 15.0% from 14.4%, driven by organic growth and operating efficiencies
- 2026 guidance raised: revenue growth 5.9% to 6.7%, adjusted EPS $18.30 to $18.70
- Four acquisitions announced or completed, targeting Diagnostics and Biopharma expansion, with expected year-one adjusted EPS accretion
- Cash $261.8M versus total debt $5.85B, while $1.4B remains authorized for share repurchases
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Labcorp 8-K filings
Get the next LH 8-K as it lands
Follow LH for push alerts, or ask the research agent what this filing means.